Literature DB >> 9808192

Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development.

S Stoll1, H Jonuleit, E Schmitt, G Müller, H Yamauchi, M Kurimoto, J Knop, A H Enk.   

Abstract

IL-18 is a recently described cytokine that shares biological activities with IL-12 in driving the development of Th1-type T cells. As dendritic cells (DC) are very potent inducers of T cell proliferation and differentiation we wondered whether they utilize IL-18 as a factor driving Th1 development. We demonstrate by Northern blot and reverse transcription-PCR that various subtypes of human and murine DC as well as the DC-line XS contain IL-18 mRNA. When supernatants of either enriched Langerhans cells (LC) or bone marrow-derived DC were analyzed for production of IL-18 protein, IL-18 production was detected in an IL-18-specific ELISA. To assess whether the IL-18 protein released by DC is functional, we performed a sensitive bioassay using the IL-18-dependent stimulation of concanavalin A-stimulated T cells. Both, supernatants from bone marrow-derived DC and enriched LC induced IFN-gamma production in the T cells. This production was partially inhibitable by addition of anti-IL-18 antiserum. In a TCR-transgenic mouse system we further demonstrate that DC-derived IL-18 potentiates IL-12-dependent Th1 development. Using DC derived from IL-12 knockout animals, we show that DC-derived IL-18 by itself is not capable of inducing Th1 cell differentiation. Together the data demonstrate that subtypes of DC are able to release functional IL-18 that is able to induce IFN-gamma production and Th1 differentiation in primed T cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9808192     DOI: 10.1002/(SICI)1521-4141(199810)28:10<3231::AID-IMMU3231>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  65 in total

1.  T cells and effector mechanisms in the pathogenesis of atopic dermatitis.

Authors:  Mübeccel Akdis; Axel Trautmann; Kurt Blaser; Cezmi A Akdis
Journal:  Curr Allergy Asthma Rep       Date:  2002-01       Impact factor: 4.806

2.  Plasma levels of interleukin-18 and interleukin-18 binding protein are elevated in patients with chronic liver disease.

Authors:  Othmar Ludwiczek; Arthur Kaser; Daniela Novick; Charles A Dinarello; Menachem Rubinstein; Wolfgang Vogel; Herbert Tilg
Journal:  J Clin Immunol       Date:  2002-11       Impact factor: 8.317

3.  Interfering with interferon-γ signalling in intestinal epithelial cells: selective inhibition of apoptosis-maintained secretion of anti-inflammatory interleukin-18 binding protein.

Authors:  D Schuhmann; P Godoy; C Weiss; A Gerloff; M V Singer; S Dooley; U Böcker
Journal:  Clin Exp Immunol       Date:  2010-11-16       Impact factor: 4.330

4.  Treatment with interleukin-18 binding protein ameliorates Toxoplasma gondii-induced small intestinal pathology that is induced by bone marrow cell-derived interleukin-18.

Authors:  D Struck; I Frank; S Enders; U Steinhoff; C Schmidt; A Stallmach; O Liesenfeld; M M Heimesaat
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

5.  β-Glucan-induced reprogramming of human macrophages inhibits NLRP3 inflammasome activation in cryopyrinopathies.

Authors:  Giorgio Camilli; Mathieu Bohm; Alícia Corbellini Piffer; Rachel Lavenir; David L Williams; Benedicte Neven; Gilles Grateau; Sophie Georgin-Lavialle; Jessica Quintin
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

Review 6.  Immunological decision-making: how does the immune system decide to mount a helper T-cell response?

Authors:  Gerard E Kaiko; Jay C Horvat; Kenneth W Beagley; Philip M Hansbro
Journal:  Immunology       Date:  2007-11-05       Impact factor: 7.397

7.  Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells.

Authors:  Hiroyuki Tada; Setsuya Aiba; Ken-Ichiro Shibata; Toshiaki Ohteki; Haruhiko Takada
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

8.  Interleukin-18 promotes joint inflammation and induces interleukin-1-driven cartilage destruction.

Authors:  Leo A B Joosten; Ruben L Smeets; Marije I Koenders; Liduine A M van den Bersselaar; Monique M A Helsen; Birgitte Oppers-Walgreen; Erik Lubberts; Yoichiro Iwakura; Fons A J van de Loo; Wim B van den Berg
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

9.  An isomeric mixture of novel cerebrosides isolated from Impatiens pritzellii reduces lipopolysaccharide-induced release of IL-18 from human peripheral blood mononuclear cells.

Authors:  Xuefeng Zhou; Lan Tang; Yonghong Liu
Journal:  Lipids       Date:  2009-07-17       Impact factor: 1.880

Review 10.  The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases.

Authors:  Cem Gabay; Iain B McInnes
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.